Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
West J Med ; 134(5): 390-3, 1981 May.
Article in English | MEDLINE | ID: mdl-7257348

ABSTRACT

Aminopyrine metabolism was studied by the aminopyrine breath test in 21 control subjects, 24 patients with untreated chronic active hepatitis (CAH), 4 patients with treated CAH and 17 patients with chronic persistent hepatitis (CPH). Aminopyrine breath tests gave abnormal results in 20 of 24 patients with untreated CAH. Findings were normal in all patients with treated CAH or with CPH. This test may be helpful in discriminating between CAH and other forms of chronic hepatitis.


Subject(s)
Aminopyrine/metabolism , Hepatitis/metabolism , Adult , Chronic Disease , Female , Hepatitis/drug therapy , Humans , Male , Prednisone/therapeutic use
2.
Am J Ophthalmol ; 91(2): 265-7, 1981 Feb.
Article in English | MEDLINE | ID: mdl-6781355

ABSTRACT

When prescribing mannitol to decrease intraocular pressure, the physician must be alert to potential complications. A 72-year-old woman suffered obtundation, intractable pulmonary edema, acidemia, and irreversible renal insufficiency despite vigorous hemodialysis. When renal function is compromised, careful monitoring of electrolyte levels, daily urine output, and renal function is necessary with mannitol therapy.


Subject(s)
Anuria/chemically induced , Glaucoma/drug therapy , Mannitol/adverse effects , Pulmonary Edema/chemically induced , Aged , Aphakia, Postcataract/complications , Female , Glaucoma/complications , Humans , Intraocular Pressure/drug effects , Mannitol/pharmacology , Mannitol/therapeutic use
3.
J Lab Clin Med ; 94(6): 947-54, 1979 Dec.
Article in English | MEDLINE | ID: mdl-501215

ABSTRACT

It is unclear whether hepatic drug metabolism which is decreased in patients with liver disease, can be stimulated by enzyme-inducing drugs. Hepatic microsomal reserve, defined as the difference between the basal and phenobarbital-stimulated ABT, was therefore studied in eight healthy control subjects and 12 patients with stable alcoholic cirrhosis. The ABT increased significantly (p less than 0.01) from a basal value of 6.1% +/- 0.8 (mean +/- S.D.) to 8.9% +/- 0.8 in the eight control subjects after phenobarbital ingestion. In the 12 patients with alcoholic cirrhosis the basal ABT was 2.9% +/- 1.5 and did not change significantly after phenobarbital ingestion, when the value was 3.0% +/- 1.6. A small increase in the ABT occurred after phenobarbital ingestion in five of the patients with alcoholic cirrhosis, but in no patient did this increase bring the ABT within normal limits. We conclude that in many patients with stable alcoholic cirrhosis aminopyrine metabolism is decreased and cannot be corrected by treatment with phenobarbital.


Subject(s)
Aminopyrine , Liver Cirrhosis, Alcoholic/metabolism , Microsomes, Liver/metabolism , Adult , Aminopyrine/metabolism , Antipyrine/metabolism , Female , Humans , Liver Cirrhosis, Alcoholic/diagnosis , Liver Cirrhosis, Alcoholic/drug therapy , Male , Middle Aged , Phenobarbital/administration & dosage , Spironolactone/administration & dosage
4.
Arch Intern Med ; 139(10): 1117-20, 1979 Oct.
Article in English | MEDLINE | ID: mdl-485743

ABSTRACT

Levels of serum triiodothyronine (T3), reverse triiodothyronine (rT3), and thyroxine (T4) were determined in 29 patients with alcoholic cirrhosis, seven patients with acute hepatitis, and 14 control patients hospitalized for chronic disease. Serum T3 levels were decreased significantly and serum rT3 levels increased significantly in the patients with alcoholic cirrhosis. Serum T3 and T4 levels were lower and rT3 levels higher in the cirrhotic patients who died within three months of the study compared with those who survived. A combination of prothrombin time, aminopyrine breath test results, and rT3 and T3 determinations gave significant predictive information about survival in patients with cirrhosis. The data suggest that assay of serum thyroid hormone levels together with prothrombin time and the aminopyrine breath test may be helpful in assessing the course and prognosis of patients with liver disease.


Subject(s)
Liver Diseases/blood , Thyroxine/blood , Adult , Aged , Breath Tests , Hepatitis/blood , Humans , Liver Cirrhosis, Alcoholic/blood , Middle Aged , Prognosis , Prothrombin Time , Triiodothyronine/blood , Triiodothyronine, Reverse/blood
5.
Gastroenterology ; 77(1): 145-7, 1979 Jul.
Article in English | MEDLINE | ID: mdl-447013

ABSTRACT

A patient with the cholestasis of Hodgkin's disease was investigated. Our studies failed to relate the cholestasis to endocrine abnormalities. The patient had severely abnormal aminopyrine metabolism, suggesting more profound hepatocellular dysfunction than had previously been appreciated.


Subject(s)
Cholestasis/etiology , Hodgkin Disease/complications , Aminopyrine , Cholestasis/metabolism , Hormones/metabolism , Humans , Liver Function Tests , Male , Middle Aged
6.
Ann Intern Med ; 90(6): 905-12, 1979 Jun.
Article in English | MEDLINE | ID: mdl-443685

ABSTRACT

Nonthyroidal illness is frequently associated with subnormal serum thyroxine (T4) and free T4 index. To unravel the resultant diagnostic problems, we have studied several variables of thyroid function in the sera of 47 patients hospitalized with nonthyroidal illnesses and seven hypothyroid patients encountered during the same period. Of the 47 euthyroid sick patients, 18 had low T4. Among these 18, free T4 index was normal in only five, whereas free T4 concentration measured by equilibrium dialysis was normal or high in 15 and 3,3',5'-triiodothyronine (reverse T3) normal or high in all 18. Reverse T3, free T4 concentration, and free T4 index were subnormal in all seven hypothyroid patients. Thus, measurement of free T4 index may be misleading in evaluation of thyroid function in patients with nonthyroidal illnesses, whereas measurement of serum concentration of reverse T3 and free T4 is quite discriminating.


Subject(s)
Thyroid Gland/physiopathology , Thyroxine/deficiency , Triiodothyronine, Reverse/blood , Triiodothyronine/blood , Adult , Aged , Diagnosis, Differential , Diagnostic Errors , Evaluation Studies as Topic , Heart Diseases/physiopathology , Humans , Hypothyroidism/diagnosis , Hypothyroidism/physiopathology , Middle Aged , Neoplasm Metastasis , Neoplasms/physiopathology , Pneumonia/physiopathology , Thyroxine/blood , Uremia/physiopathology
7.
Dig Dis Sci ; 24(5): 339-44, 1979 May.
Article in English | MEDLINE | ID: mdl-456221

ABSTRACT

In order to assess the usefulness of nasogastric suction in acute alcoholic pancreatitis, 37 patients with alcoholic pancreatitis were prospectively investigated. The study failed to demonstrate efficacy of nasogastric suction in those patients with mild disease. Application of a system of prognostic signs proved useful in discriminating between mild and severe disease. Routine use of ultrasound examinations detected three pancreatic pseudocysts before they became clinically apparent. In instituting appropriate therapy in mild pancreatitis, factors such as patient comfort should be considered in the absence of proven significant value of nasogastric suction.


Subject(s)
Alcoholism/therapy , Pancreatitis/therapy , Adult , Alcoholism/complications , Alcoholism/pathology , Evaluation Studies as Topic , Female , Humans , Intubation, Gastrointestinal , Male , Methods , Middle Aged , Pancreatic Cyst/complications , Pancreatic Cyst/diagnosis , Pancreatitis/complications , Pancreatitis/pathology , Prognosis , Prospective Studies , Risk , Suction , Ultrasonography
9.
Gastroenterology ; 76(2): 267-71, 1979 Feb.
Article in English | MEDLINE | ID: mdl-103777

ABSTRACT

Rats pretreated with three agents known to stimulate cytochrome P-448-associated enzymes, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 3-methylcholanthrene (3MC), and Aroclor 1254 were studied with a 14CO2 breath analysis technique after administration of [14C-dimethyl]aminoazobenzene (DMAB). The half-life of breath 14CO2 after [14C]DMAB administration was significantly decreased in the TCDD-, 3MC-, and Aroclor 1254-treated rats compared with controls. In vitro studies indicated that DMAB N-demethylase was increased by these three agents. Phenobarbital, an inducer of cytochrome P-450-associated enzymes, had no effect on 14CO2 half-life or on DMAB N-demethylase. Studies with [14C]aminopyrine, a cytochrome P-450 substrate, showed that TCDD and 3MC had no effect on 14CO2 half-life or aminopyrine N-demethylase; Aroclor 1254 and phenobarbital decreased 14CO2 half-life and stimulated aminopyrine N-demethylase. The data suggest that a [14C]DMAB breath analysis technique may be useful for in vivo studies of inducers of cytochrome P-448.


Subject(s)
Aroclors/pharmacology , Breath Tests , Carbon Dioxide/analysis , Dioxins/pharmacology , Liver/enzymology , Methylcholanthrene/pharmacology , Oxidoreductases, N-Demethylating/metabolism , Polychlorinated Biphenyls/pharmacology , Polychlorinated Dibenzodioxins/pharmacology , p-Dimethylaminoazobenzene , Aminopyrine N-Demethylase/metabolism , Animals , Carbon Radioisotopes , Cytochromes , Dioxanes/pharmacology , Enzyme Induction , Evaluation Studies as Topic , Liver/drug effects , Male , Methods , Phenobarbital/pharmacology , Rats
10.
Clin Pharmacol Ther ; 25(2): 196-8, 1979 Feb.
Article in English | MEDLINE | ID: mdl-759072

ABSTRACT

In order to assess the effect of norethindrone on hepatic drug metabolism in man, hepatic N-demethylation of aminopyrine was studied by means of the aminopyrine breath test (ABT) in 7 healthy women during two menstrual cycles. Aminopyrine metabolic clearance rates were also studied in 3 women. The women were examined at the ends of the first, second, and third weeks before starting progestogen therapy and at the same times during a second menstrual cycle during which they took norethindrone, 350 microgram/day. The ABT was 5.1 +/- 1.9% (mean +/- SD) during the three control weeks and lower (p less than 0.001) during the three weeks on norethindrone, 3.9 +/- 0.9%. Aminopyrine metabolic clearance rate also fell during norethindrone therapy. The data suggest that progestogens inhibit hepatic microsomal function.


Subject(s)
Liver/drug effects , Norethindrone/pharmacology , Pharmaceutical Preparations/metabolism , Adult , Aminopyrine/metabolism , Breath Tests , Female , Humans , Liver/metabolism , Metabolic Clearance Rate/drug effects
12.
Am J Med ; 65(6): 1015-20, 1978 Dec.
Article in English | MEDLINE | ID: mdl-742623

ABSTRACT

In this 54 year old woman with celiac disease, osteomalacia developed while she was on a gluten-free diet which had caused regression of her steatorrhea. She was not responsive to large doses of parenterally administered dihydrotachysterol and calcium, but she was responsive to the oral administration of 25-hydroxyvitamin D3 (25-OHD3). The data suggest that 25-OHD3 is the treatment of choice for patients with vitamin D deficiency due to intestinal malabsorption.


Subject(s)
Celiac Disease/complications , Hydroxycholecalciferols/therapeutic use , Osteomalacia/etiology , Administration, Oral , Adult , Celiac Disease/diet therapy , Female , Glutens , Humans , Hydroxycholecalciferols/administration & dosage , Middle Aged , Osteomalacia/drug therapy , Vitamin D Deficiency/complications
14.
Am J Med ; 65(2): 371-6, 1978 Aug.
Article in English | MEDLINE | ID: mdl-686023

ABSTRACT

Aminopyrine disposition was studied in 11 patients with congestive heart failure (CHF) and 15 control patients. The aminopyrine metabolic clearance rate was 29.7 +/- 7.1 ml/min (mean +/- SEM) in the patients with CHF and 125.1 +/- 5.7 ml/min (mean +/- SEM) in the control patients (p less than 0.01). The aminopyrine breath test was 2.6 +/- 0.4 per cent (mean +/- SEM) in the patients with CHF and 5.6 +/- 0.3 per cent (mean +/- SEM) in the control subjects (p less than 0.01). Probably due to fluid retention in CHF, the apparent volume of distribution of aminopyrine increased to 63.3 +/- 4.9 liters (mean +/- SEM) in patients with CHF from 43.1 +/- 1.9 liters (mean +/- SEM) in control patients, thereby further impairing aminopyrine elimination in patients with CHF (p less than 0.01). The aminopyrine breath test was measured in a group of eight patients before treatment for an acute episode of CHF and seven to 10 days after initiation of therapy: in each patient clinical improvement was associated with an increased aminopyrine breath test, mean values of aminopyrine breath test increasing from 2.8 per cent before treatment to 5.2 per cent after initiation of treatment (p less than 0.01). These results suggest that in patients with CHF hepatic drug-metabolizing activity is imparied, and the volume of distribution of drugs is increased, with consequent retardation in rates of drug elimination.


Subject(s)
Aminopyrine/metabolism , Heart Failure/metabolism , Aged , Aminopyrine/therapeutic use , Biological Availability , Biotransformation , Breath Tests , Female , Heart Failure/drug therapy , Humans , Liver/metabolism , Male , Metabolic Clearance Rate , Middle Aged , Models, Biological , Time Factors
17.
Cancer ; 41(5): 1680-4, 1978 May.
Article in English | MEDLINE | ID: mdl-647621

ABSTRACT

The effect of immunotherapy and chemotherapy on hepatic N-demethylation of aminopyrine was studied by means of the aminopyrine breath test (ABT) in 32 patients with cancer. The aminopyrine breath test (ABT) was decreased in 3 of 11 patients (27.3%) receiving intradermal BCG (+/- DTIC) at a dose of 3 X 10(7) viable organisms. One of 4 (25%) patients receiving intradermal BCG (+/- DTIC) at 3 X 10(8) viable organisms per dose developed an altered ABT. Changes were not seen in patients receiving aerosol BCG (2 patients), and intravenous C. parvum (2 patients), subcutaneous C. parvum (3 patients), and intravenous Cyclophosphamide (2 patients). Six of 7 patients (85.7%) receiving both intravenous C. parvum and Cyclophosphamide had a decreased ABT. These data indicate that chemo-immunotherapy depressed hepatic aminopyrine N-demethylation and suggests that patients treated with chemoimmunotherapy should be carefully observed for possible alterations of hepatic drug metabolism.


Subject(s)
Aminopyrine/metabolism , BCG Vaccine/adverse effects , Cyclophosphamide/adverse effects , Immunotherapy/adverse effects , Liver/metabolism , Neoplasms/metabolism , Propionibacterium acnes/immunology , Adult , Aged , Aminopyrine N-Demethylase/metabolism , Biotransformation/drug effects , Breath Tests , Dacarbazine/adverse effects , Female , Humans , Liver/drug effects , Male , Middle Aged , Mixed Function Oxygenases/metabolism , Neoplasms/therapy
20.
Radiology ; 124(1): 213-6, 1977 Jul.
Article in English | MEDLINE | ID: mdl-405708

ABSTRACT

Thirty-three patients with gynecological neoplasms undergoing radiotherapy to the pelvis had cholyl[1-14C]glycine breath tests to assess ileal function. Breath tests were performed on each patient in the first and fifth weeks of treatment and 19 of the patients had a third test three months post-treatment. In the first test, 29.9+/-16.8% (mean+/-SD) of the administered dose was excreted in breath 14C in 24 hours. This rose to 47.3+/-15.9% (t=6.08; p less than .001) in the fifth week and fell to 36.6+/-16% (t=2.29; p less than .05) at three months post-treatment. Eight patients had breath tests performed one year post-treatment and the test percentages were 32.7+/-7.8% (t=1.19; p less than .10). The increase in 14CO2 excretion in the fifth week of treatment occurred at a time when most patients were having diarrhea. The data suggest that bile acid malabsorption due to ileal dysfunction may be a factor in radiation-induced diarrhea which occurs in nearly all patients during pelvic irradiation.


Subject(s)
Genital Neoplasms, Female/radiotherapy , Ileum/radiation effects , Radiotherapy/adverse effects , Adult , Aged , Cobalt Radioisotopes , Female , Humans , Ileum/physiopathology , Middle Aged , Radiation Injuries/physiopathology , Radioisotope Teletherapy/adverse effects , Radiotherapy, High-Energy/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...